Chemoinformaics analysis of Acetylatractylodinol
Molecular Weight | 240.258 | nRot | 3 |
Heavy Atom Molecular Weight | 228.162 | nRig | 10 |
Exact Molecular Weight | 240.079 | nRing | 1 |
Solubility: LogS | -3.17 | nHRing | 1 |
Solubility: LogP | 3.384 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
nHA | 3 | APOL | 35.4575 |
nHD | 0 | BPOL | 16.3785 |
QED | 0.601 |
Synth | 3.412 |
Natural Product Likeliness | 1.413 |
NR-PPAR-gamma | 0.213 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.13 |
Pgp-sub | 0.001 |
HIA | 0.144 |
CACO-2 | -4.302 |
MDCK | 0.0000236 |
BBB | 0.007 |
PPB | 1.00727 |
VDSS | 2.865 |
FU | 0.0203997 |
CYP1A2-inh | 0.991 |
CYP1A2-sub | 0.089 |
CYP2c19-inh | 0.952 |
CYP2c19-sub | 0.152 |
CYP2c9-inh | 0.954 |
CYP2c9-sub | 0.493 |
CYP2d6-inh | 0.923 |
CYP2d6-sub | 0.19 |
CYP3a4-inh | 0.892 |
CYP3a4-sub | 0.327 |
CL | 5.979 |
T12 | 0.767 |
hERG | 0.064 |
Ames | 0.722 |
ROA | 0.943 |
SkinSen | 0.966 |
Carcinogencity | 0.453 |
EI | 0.97 |
Respiratory | 0.929 |
NR-Aromatase | 0.852 |
Antiviral | Yes |
Prediction | 0.5672 |